SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemo Pharma Laboratories informs about trading window closure

29 Dec 2022 Evaluate

Pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 and Company’s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, Chemo Pharma Laboratories has informed that the Trading Window of the Company shall remain closed for all the Designated Persons and their relatives with effect from January 01, 2023 till 48 hours after the financial results of the Company for the quarter ended December 31, 2022 becomes generally available information.

The above information is a part of company’s filings submitted to BSE.

Starsource Multitrad Share Price

116.50 -6.10 (-4.98%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×